Journal article icon

Journal article

Situational analysis of antibiotic prescriptions in Kenyan neonatal units for antimicrobial stewardship: a retrospective longitudinal study

Abstract:
Background
High antibiotic use in neonatal units may drive antimicrobial resistance and cause harm including mortality. We used data from 22 Kenyan neonatal units to (1) describe the proportion with antibiotic prescriptions at admission; (2) assess the predictors of non-first line antibiotic prescription; (3) estimate antibiotic use, and (4) explore postadmission antibiotic switching.
Methods
Retrospective longitudinal study from 1st September 2020 to 31st October 2023. Antibiotics were classified as first line (penicillin plus gentamicin only), third generation cephalosporins (ceftazidime or ceftriaxone) or others. The proportion of antibiotic prescriptions were computed, and a multilevel logistic regression model used to analyse predictors of non-first line prescription. Antibiotic use was quantified by days of therapy (DOT) and length of therapy (LOT).
Findings
Most neonates–62.6% (51,883/82,834)- received at least one antibiotic prescription at admission. Overall, first line antibiotics constituted 86% (44,636/51,883) but third generation cephalosporin use reached 100% in two facilities temporarily. The odds of non-first line prescription was greatest for outborn neonates (Odds ratio 2.27, 95% CI 2.12–2.43) while the estimated antibiotic consumption was 418 (389–500) per 1000 patient days by LOT and 744 (691–869) by DOT. From exploratory data post admission switching was most commonly to third generation cephalosporins.
Interpretation
There is a high use of antibiotics potentially related to severity of illness at admission. Adherence to national guidelines for first line antibiotics is however generally high. Estimation of neonatal antibiotic prescription patterns and use over time and place is feasible and will be important in assessing the effectiveness of antimicrobial stewardship in Kenya and elsewhere in reducing antimicrobial resistance.
Funding
This work was funded by the Wellcome Trust.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1016/j.eclinm.2025.103156

Authors

More by this author
Role:
Author
ORCID:
0000-0002-0851-3711
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Sub unit:
Centre for Tropical Medicine and Global Health at Oxford
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
NDM
Sub department:
Tropical Medicine
Sub unit:
Centre for Tropical Medicine and Global Health at Oxford
Role:
Author
ORCID:
0000-0002-2559-797X


More from this funder
Funder identifier:
https://ror.org/029chgv08
Grant:
092654/Z/10/A
207522/Z/17/Z


Publisher:
Elsevier
Journal:
EClinicalMedicine More from this journal
Volume:
82
Article number:
103156
Place of publication:
England
Publication date:
2025-03-25
Acceptance date:
2025-02-27
DOI:
EISSN:
2589-5370
Pmid:
40212050


Language:
English
Keywords:
Pubs id:
2101561
Local pid:
pubs:2101561
Deposit date:
2025-05-07
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP